{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:17:49Z","timestamp":1787509069475,"version":"build-2736575974"},"reference-count":26,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"unspecified","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002193","name":"Lupus Foundation of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002193","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR071653"],"award-info":[{"award-number":["R01AR071653"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2021,2,4]]},"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>There is a need to identify concerns unique to patients with cutaneous lupus erythematosus (CLE), which may not be captured by current common-practice dermatological quality-of-life tools. This study formally characterises what bothers patients with CLE about their disease by conducting semistructured, qualitative interviews.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Sixteen patients with CLE were interviewed about how their cutaneous findings impact their daily life. Each interview was transcribed, coded and categorised for recurrent themes. Current CLE activity and damage were also assessed by the Cutaneous Lupus Activity and Severity Index tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Responses were categorised into six themes, including Fear of Disease Progression, Unwanted Attention, Self-Consciousness, Physical Signs\/Symptoms, Emotional Symptoms and Functional Decline. The most commonly reported themes were Self-Consciousness, mentioned by 13 of 16 (81.3%) patients, Physical Symptoms, mentioned by 12 of 16 (75%), and then Fear of Disease Progression, by 11 of 16 (68.8%). Frequently mentioned physical signs\/symptoms included erythema, itch, dyspigmentation, scar and alopecia. The physical signs\/symptoms were categorised as activity signs\/symptoms, damage signs and other. For activity signs, erythema was mentioned most frequently (5 of 16), then scale (2 of 16). For activity symptoms, itch was mentioned most frequently (6 of 16), then pain (5 of 16). For damage signs, dyspigmentation was mentioned most frequently (4 of 16), followed by scarring (3 of 16). Patients less than 60 years old were more likely to report emotional symptoms than older patients (p&lt;0.05), but there was no significant variation in frequency of reported themes between race, sex or subtype of CLE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These patient experiences and resultant themes elucidated by this study are worth noting in future standardised estimations of the quality of life of patients with CLE. Additionally, the concerns shown by these interviews are important topics for providers to discuss when evaluating patient disease progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/lupus-2020-000444","type":"journal-article","created":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T12:22:18Z","timestamp":1630066938000},"page":"e000444","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Cutaneous lupus concerns from the patient perspective: a qualitative study"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0863-7201","authenticated-orcid":false,"given":"Daisy","family":"Yan","sequence":"first","affiliation":[{"name":"Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA"},{"name":"Dermatology, Corporal Michael J Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Zamalin","sequence":"additional","affiliation":[{"name":"Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA"},{"name":"Dermatology, Corporal Michael J Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srita","family":"Chakka","sequence":"additional","affiliation":[{"name":"Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA"},{"name":"Dermatology, Corporal Michael J Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Krain","sequence":"additional","affiliation":[{"name":"Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA"},{"name":"Dermatology, Corporal Michael J Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Concha","sequence":"additional","affiliation":[{"name":"Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA"},{"name":"Dermatology, Corporal Michael J Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Feng","sequence":"additional","affiliation":[{"name":"Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA"},{"name":"Dermatology, Corporal Michael J Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Okawa","sequence":"additional","affiliation":[{"name":"Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA"},{"name":"Dermatology, Corporal Michael J Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria P","family":"Werth","sequence":"additional","affiliation":[{"name":"Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA"},{"name":"Dermatology, Corporal Michael J Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,8,27]]},"reference":[{"key":"2025091512555468000_8.1.e000444.1","unstructured":"Bolognia J , Schaffer JV , Cerroni L . Dermatology. Fourth edition, 2021."},{"key":"2025091512555468000_8.1.e000444.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2013.07.008"},{"key":"2025091512555468000_8.1.e000444.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(02)00016-5"},{"key":"2025091512555468000_8.1.e000444.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.02.008"},{"key":"2025091512555468000_8.1.e000444.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.06.017"},{"key":"2025091512555468000_8.1.e000444.6","unstructured":"Callen JP , Jorizzo JL , Bolognia JL . Dermatological signs of internal disease E-Book: expert Consult-Online and print: Elsevier health sciences, 2009."},{"key":"2025091512555468000_8.1.e000444.7","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/bjd.17636","article-title":"Validation and reliability of a disease\u2010specific quality\u2010of\u2010life measure in patients with cutaneous lupus erythematosus","volume":"180","author":"Ogunsanya","year":"2019","journal-title":"Br J Dermatol"},{"key":"2025091512555468000_8.1.e000444.8","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1111\/bjd.15902","article-title":"Cutaneous lupus erythematosus: quality of life and related factors in a cohort of 260 patients from a Coru\u00f1a, Spain","volume":"178","author":"Ar\u00e9valo-Berm\u00fadez","year":"2018","journal-title":"Br J Dermatol"},{"key":"2025091512555468000_8.1.e000444.9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s40257-019-00429-7","article-title":"Chronic cutaneous lupus erythematosus: depression burden and associated factors","volume":"20","author":"Hong","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"2025091512555468000_8.1.e000444.10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijwd.2018.01.002","article-title":"Understanding the disease burden and unmet needs among patients with cutaneous lupus erythematosus: a qualitative study","volume":"4","author":"Ogunsanya","year":"2018","journal-title":"Int J Womens Dermatol"},{"key":"2025091512555468000_8.1.e000444.11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/A:1004844425448","article-title":"Statistical analysis of sensitive topics in group and individual interviews","volume":"34","author":"Kaplowitz","year":"2000","journal-title":"Quality and Quantity"},{"key":"2025091512555468000_8.1.e000444.12","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0376"},{"key":"2025091512555468000_8.1.e000444.13","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1082"},{"key":"2025091512555468000_8.1.e000444.14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2340\/00015555-1823","article-title":"Qualitative interviews on chronic pruritus in haemodialysis patients","volume":"94","author":"Weiss","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"2025091512555468000_8.1.e000444.15","first-page":"586","article-title":"Using scribes in qualitative research as an alternative to transcription","volume":"24","author":"Eaton","year":"2019","journal-title":"The Qualitative Report"},{"key":"2025091512555468000_8.1.e000444.16","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22032"},{"key":"2025091512555468000_8.1.e000444.17","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.037077"},{"key":"2025091512555468000_8.1.e000444.18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40337-017-0177-8","article-title":"The role of personality in body image dissatisfaction and disordered eating: discrepancies between men and women","volume":"5","author":"MacNeill","year":"2017","journal-title":"J Eat Disord"},{"key":"2025091512555468000_8.1.e000444.19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1529-8019.2008.00205.x","article-title":"Cicatricial alopecia: discoid lupus erythematosus","volume":"21","author":"Hordinsky","year":"2008","journal-title":"Dermatol Ther"},{"key":"2025091512555468000_8.1.e000444.20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/1744666X.2019.1543591","article-title":"The relationship between smoking, psoriasis and psoriatic arthritis","volume":"15","author":"Pezzolo","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"2025091512555468000_8.1.e000444.21","first-page":"9","article-title":"Understanding the relationship between smoking and hidradenitis suppurativa","volume":"28","author":"Bukvi\u0107 Mokos","year":"2020","journal-title":"Acta Dermatovenerol Croat"},{"key":"2025091512555468000_8.1.e000444.22","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1111\/bjd.15902","article-title":"Cutaneous lupus erythematosus: quality of life and related factors in a cohort of 260 patients from a Coru\u00f1a, Spain","volume":"178","author":"Ar\u00e9valo-Berm\u00fadez","year":"2018","journal-title":"Br J Dermatol"},{"key":"2025091512555468000_8.1.e000444.23","doi-asserted-by":"publisher","DOI":"10.1177\/0961203313509293"},{"key":"2025091512555468000_8.1.e000444.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1995.tb04656.x"},{"key":"2025091512555468000_8.1.e000444.25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5114\/reum.2018.74750","article-title":"Quality of life in systemic lupus erythematosus and its measurement","volume":"56","author":"Olesi\u0144ska","year":"2018","journal-title":"Reumatologia"},{"key":"2025091512555468000_8.1.e000444.26","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-018-0594-7"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2020-000444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T19:56:05Z","timestamp":1757966165000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2020-000444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,8,27]]},"published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.1136\/lupus-2020-000444"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2020-000444","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8]]}}}